title: Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.
authors.forename: S N
authors.initials: SN
authors.lastname: Finkelstein
authors.forename: S L
authors.initials: SL
authors.lastname: Huber
authors.forename: P E
authors.initials: PE
authors.lastname: Greenberg
mesh_terms: D000740:Anemia / Q000139:chemically induced* / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001803:Blood Transfusion / Q000191:economics*; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000191:economics* / Q000627:therapeutic use; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D004921:Erythropoietin